Search & Filter
Date Range
Resource Type
HRS Endorsed
Audience
Topic
Manufacturer
Device Type
FDA Class
Clinical Trials
The ARISTOTLE Trial
In patients with atrial fibrillation, apixaban was superior to warfarin in preventing stroke or systemic embolism, caused less bleeding, and resulted in lower mortality.
September 15, 2011
Clinical Trials
The ROCKET AF Trial
In patients with atrial fibrillation, rivaroxaban (factor Xa inhibition) was noninferior to warfarin (vitamin K antagonists) for the prevention of stroke or systemic embolism.
September 8, 2011
Clinical Documents
2011 HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies
The statement focuses primarily on the state of genetic testing for 13 distinct entities and the relative diagnostic, prognostic, and therapeutic impact of the genetic…
August 1, 2011
Clinical Documents
2011 HRS Policy Statement: Clinical Cardiac Electrophysiology Fellowship Curriculum
A fellowship curriculum is indispensable in the training of a clinical cardiac electrophysiologist. This update focuses on what a practicing electrophysiologist will need in the care…
August 1, 2011
Clinical Documents
2011 HRS/ASA Expert Consensus Statement on the Perioperative Management of Patients with Implantable Defibrillators, Pacemakers, and Arrhythmia Monitors: Facilities and Patient Management
Developed as a joint project with the American Society of Anesthesiologists (ASA) and in collaboration with the American Heart Association (AHA) and the Society of…
July 1, 2011
Clinical Documents
2011 Guidance for the Heart Rhythm Society Pertaining to Interactions with Industry
On October 18, 2010, HRS convened the Relationships with Industry Task Force to consider whether it should continue to collaborate with industry, why collaboration may…
April 26, 2011
Clinical Trials
The AVERROES Trial
In patients with atrial fibrillation for whom vitamin K antagonist therapy was unsuitable, apixaban reduced the risk of stroke or systemic embolism without significantly increasing…
March 3, 2011
Clinical Documents
2011 ACCF/AHA/HRS Focused Update on the Management of Patients with Atrial Fibrillation (Update on Dabigatran)
This guideline update states that dabigatran, a new antithrombotic agent that was recently approved by the U.S. Food and Drug Administration, is an alternative to…
February 14, 2011
Clinical Documents
2011 ACCF/AHA/HRS Focused Update on the Management of Patients with Atrial Fibrillation (Updating the 2006 Guideline)
This guideline update focuses on several areas in which new data on management of patients with atrial fibrillation (AF) have become available, including a) recommendations…
December 20, 2010
Clinical Trials
The RAFT Trial
In patients with mild to moderate heart failure and a wide QRS complex, the addition of CRT to an ICD reduced rates of death and…
December 16, 2010